COVID-19 como evento disruptivo na ecologia viral: repercussões para as síndromes respiratórias agudas graves e para a interpretação das sequelas pós-infecciosas
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
The COVID-19 pandemic acted as a disruptive event in respiratory viral ecology, reshaping
seasonality, co-circulation patterns, and the clinical interpretation of acute respiratory
syndromes and their post-infectious sequelae. This thesis integrates evidence from three
complementary approaches addressing distinct phases and consequences of the pandemic in
Minas Gerais, Brazil. During the pandemic phase (February to September 2021), a retrospective
study in the Zona da Mata region analyzed respiratory samples processed by the molecular
diagnostics service at ICB/UFJF, combining genomic surveillance (whole-genome sequencing)
to characterize SARS-CoV-2 variants with molecular screening for other major respiratory
viruses (human rhinovirus [HRV], respiratory syncytial virus [RSV], and influenza A/B),
alongside clinical–epidemiological analyses and statistical modeling. In this period, the Gamma
variant predominated and was associated with greater clinical severity compared with Delta
(OR ~3.0; 95% CI: 1.21–7.32), with evidence of reduced influenza and RSV circulation during
peaks of COVID-19 activity. Comorbidities such as diabetes (OR 2.14; 95% CI: 1.21–3.79)
and obesity (OR 7.02; 95% CI: 1.49–33.00) were associated with SARS-CoV-2 infection, and
heart disease showed an independent association with Gamma infection (aOR 3.54; 95% CI:
1.99–6.29). In the post-pandemic period (2023–2024), a second retrospective study evaluated
severe acute respiratory illness cases (SRAG/SARI) from the Barbacena and Leopoldina
regions processed at the SES/MG collaborating center at ICB/UFJF, integrating RT-qPCR
(including multiplex assays) with clinical and epidemiological data. Among 264 samples from
36 municipalities, most cases were from urban residents (90.77%), with a heterogeneous age
distribution (median 14 years). RSV (14.77%), HRV (11.36%), influenza A/B (9.46%), and
SARS-CoV-2 (7.95%) were detected, while coinfections were uncommon (2.65%). A high
proportion of SRAG/SARI cases remained without an identified viral etiology (53.78%),
underscoring persistent diagnostic gaps despite expanded molecular testing capacity. Temporal
patterns were atypical for influenza (peak in August 2024) and indicated a substantial RSVrelated hospitalization burden (increase from March to June 2024, peaking in May), whereas
SARS-CoV-2 circulation was more sporadic. Across both phases, multivariate analyses support
that clinical overlap among respiratory viruses remains a major barrier to syndromic
management, and viral coinfections were not consistently associated with worse outcomes in
the studied settings. Finally, a narrative synthesis discusses long COVID as a multisystem postinfectious condition characterized by heterogeneous definitions, lack of biomarkers, and
significant impacts on quality of life and healthcare systems, exacerbated by misinformation,
stigma, and inequalities in access to care. Overall, the findings reinforce the need for sustained,
integrated respiratory virus surveillance beyond SARS-CoV-2, broader access to multiplex
molecular diagnostics, strengthened vaccination strategies, and coordinated public health
approaches that connect laboratory evidence, clinical decision-making, and preparedness for
future respiratory health emergencies.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

